Oct. 5, 2009--KUREHA CORPORATION and Mitsubishi Tanabe Pharma Corporation have entered into an agreement, effective on November 1, 2009, under which KUREHA shall grant Mitsubishi Tanabe a license to market Kremezin® in Japan, a drug for chronic renal failure developed by KUREHA.
The details can be read here.
No comments:
Post a Comment